High-dose melphalan and autologous bone marrow transplantation as consolidation in previously untreated myeloma.

Abstract

Myeloma patients who are able to receive HDM plus ABMT following conventional chemotherapy achieve a high proportion of CRs, which may be associated with prolonged survival.